Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected wounds

被引:7
作者
Six, Robert [1 ]
Cleaver, Dawn M. [1 ]
Lindeman, Cindy J. [1 ]
Cherni, Judith [1 ]
Chesebrough, Robert [1 ]
Papp, Georg [1 ]
Skogerboc, Terry L. [1 ]
Weigel, Dan J. [1 ]
Boucher, Joseph F. [1 ]
Stegemann, Michael R. [1 ]
机构
[1] Pfizer Anim Hlth, Kalamazoo, MI 49001 USA
来源
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2009年 / 234卷 / 01期
关键词
ANTIMICROBIAL SUSCEPTIBILITY; STAPHYLOCOCCI; DOGS; RESISTANCE;
D O I
10.2460/javma.234.1.81
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To evaluate the effectiveness and safety of cefovecin sodium in the treatment of cats with naturally occurring skin infections (abscesses and infected wounds). Design-Multicenter (26 sites), randomized, double-blind, controlled clinical trial. Animals-Client-owned cats of any breed with naturally occurring skin infections with associated clinical signs and confirmatory bacteriologic culture results. Procedures-Cats with clinical signs of skin and soft tissue infection were randomly allocated to receive a single dose of cefovecin (8 mg/kg 13.6 mg/lb], SC) followed by placebo drops administered orally once daily for 14 days or I SC placebo injection followed by cefadroxil (22 mg/kg [10 mg/lb], PO, once daily for 14 days). Only one 14-day treatment course was permitted. Results-Effectiveness of cefovecin in the treatment of cats with abscesses and infected wounds was similar to that of cefadroxil. At the final assessment on day 28, 97% (86/89) of cefovecin-treated cats and 91 % (80/88) of cefadroxil-treated cats were considered treatment successes. There were no serious adverse events or deaths related to treatment. Conclusions and Clinical Relevance-1 SC injection of 8 mg of cefovecin/kg for safe and as effective as cefacroxil administered orally at 22 mg/kg, once daily for 14 days. (J Am Vet Med Assoc 20091-234:81-87)
引用
收藏
页码:81 / 87
页数:7
相关论文
共 31 条
  • [21] Antimicrobial resistance of feline staphylococci in southeastern England
    Patel, A
    Lloyd, DH
    Lamport, AI
    [J]. VETERINARY DERMATOLOGY, 1999, 10 (03) : 257 - 261
  • [22] Prescott J.F., 2000, Antimicrobial Therapy in Veterinary Medicine, P134
  • [23] Quinn PJ., 2002, Veterinary microbiology and microbial disease, V1st
  • [24] SCANLAN CM, 1988, INTRO VET BACTERIOLO, P365
  • [25] Aspects of bacterial resistance to antimicrobials used in veterinary dermatological practice
    Schwarz, S
    Noble, WC
    [J]. VETERINARY DERMATOLOGY, 1999, 10 (03) : 163 - 176
  • [26] The efficacy and safety of cefovecin in the treatment of feline abscesses and infected wounds
    Stegemann, M. R.
    Sherington, J.
    Passmore, C.
    [J]. JOURNAL OF SMALL ANIMAL PRACTICE, 2007, 48 (12) : 683 - 689
  • [27] Pharmacokinetics of cefovecin in cats
    Stegemann, M. R.
    Sherington, J.
    Coati, N.
    Brown, S. A.
    Blanchflower, S.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2006, 29 (06) : 513 - 524
  • [28] Antimicrobial activity and spectrum of cefovecin, a new extended-spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America
    Stegemann, M. R.
    Passmore, C. A.
    Sherington, J.
    Lindeman, C. J.
    Papp, G.
    Weigel, D. J.
    Skogerboe, T. L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2286 - 2292
  • [29] VADEN SL, 1995, KIRKS CURRENT VET TH, V12, P276
  • [30] WILLARD MD, 1989, SMALL ANIMAL CLIN DI, P150